PH14778A - 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile - Google Patents

4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile

Info

Publication number
PH14778A
PH14778A PH21883A PH21883A PH14778A PH 14778 A PH14778 A PH 14778A PH 21883 A PH21883 A PH 21883A PH 21883 A PH21883 A PH 21883A PH 14778 A PH14778 A PH 14778A
Authority
PH
Philippines
Prior art keywords
androstane
carbonitrile
oxo
hydroxy
epoxy
Prior art date
Application number
PH21883A
Other languages
English (en)
Inventor
Robert George Christiansen
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PH14778A publication Critical patent/PH14778A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PH21883A 1977-12-20 1978-12-04 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile PH14778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (1)

Publication Number Publication Date
PH14778A true PH14778A (en) 1981-12-09

Family

ID=25338450

Family Applications (2)

Application Number Title Priority Date Filing Date
PH21883A PH14778A (en) 1977-12-20 1978-12-04 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile
PH23081A PH16835A (en) 1977-12-20 1979-09-28 Isoxazole steroids and process for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH23081A PH16835A (en) 1977-12-20 1979-09-28 Isoxazole steroids and process for the preparation thereof

Country Status (27)

Country Link
US (1) US4160027A (da)
JP (2) JPS5488253A (da)
AR (1) AR222645A1 (da)
AT (1) AT367070B (da)
AU (1) AU518997B2 (da)
BE (1) BE872886A (da)
CA (1) CA1121340A (da)
CH (1) CH637409A5 (da)
DE (1) DE2855091A1 (da)
DK (1) DK156727C (da)
ES (1) ES476117A1 (da)
FI (1) FI66010C (da)
FR (1) FR2412569A1 (da)
GB (2) GB2010278B (da)
HK (1) HK89287A (da)
IE (1) IE48076B1 (da)
IL (1) IL56076A (da)
IT (1) IT1195258B (da)
LU (1) LU80673A1 (da)
MX (1) MX5535E (da)
NL (1) NL190848C (da)
NO (1) NO151467C (da)
NZ (1) NZ189035A (da)
PH (2) PH14778A (da)
PT (1) PT68926A (da)
SE (1) SE433221B (da)
ZA (1) ZA786746B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
JPS5995300A (ja) * 1982-11-02 1984-06-01 スタ−リング・ドラッグ・インコ−ポレ−テッド コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物
DK23984A (da) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroider
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (de) * 1985-09-05 1987-03-12 Schering Ag Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (ja) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd 車両用空気調和装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
EP2468282A3 (en) * 2005-07-12 2012-09-12 DMI Biosciences, Inc. Methods and products for treatment of diseases
SG10201403388SA (en) * 2009-06-22 2014-10-30 Ampio Pharmaceuticals Inc Methods and products for treatment of diseases
PL2425839T3 (pl) 2009-06-22 2015-03-31 Ampio Pharmaceuticals Inc Sposób leczenia chorób
JP2016503794A (ja) 2012-12-19 2016-02-08 アンピオ ファーマシューティカルズ，インコーポレイテッド 疾患の治療のための方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
NO784281L (no) 1979-06-21
AU4208978A (en) 1979-06-28
NL7812309A (nl) 1979-06-22
AU518997B2 (en) 1981-10-29
IT1195258B (it) 1988-10-12
IE782492L (en) 1979-06-20
NL190848B (nl) 1994-04-18
JPS62142198A (ja) 1987-06-25
ATA888578A (de) 1981-10-15
SE7813067L (sv) 1979-06-21
ES476117A1 (es) 1979-11-16
GB2010278B (en) 1982-10-20
IL56076A (en) 1983-06-15
GB2088878A (en) 1982-06-16
IT7831011A0 (it) 1978-12-19
DE2855091C2 (da) 1988-12-22
SE433221B (sv) 1984-05-14
MX5535E (es) 1983-09-27
IE48076B1 (en) 1984-09-19
US4160027A (en) 1979-07-03
ZA786746B (en) 1979-11-28
AT367070B (de) 1982-05-25
NO151467B (no) 1985-01-02
GB2010278A (en) 1979-06-27
PH16835A (en) 1984-03-15
JPS6361314B2 (da) 1988-11-28
GB2088878B (en) 1983-01-19
JPS5488253A (en) 1979-07-13
PT68926A (en) 1979-01-01
FR2412569B1 (da) 1982-05-28
FI66010C (fi) 1984-08-10
FI66010B (fi) 1984-04-30
DK156727B (da) 1989-09-25
JPS6220998B2 (da) 1987-05-11
CH637409A5 (fr) 1983-07-29
IL56076A0 (en) 1979-01-31
NL190848C (nl) 1994-09-16
NO151467C (no) 1985-04-17
DK156727C (da) 1990-03-12
DK569678A (da) 1979-06-21
LU80673A1 (fr) 1979-07-20
AR222645A1 (es) 1981-06-15
FR2412569A1 (fr) 1979-07-20
HK89287A (en) 1987-12-11
CA1121340A (en) 1982-04-06
NZ189035A (en) 1980-08-26
FI783901A (fi) 1979-06-21
DE2855091A1 (de) 1979-06-28
BE872886A (fr) 1979-06-20

Similar Documents

Publication Publication Date Title
ZA785001B (en) 1-phenyl-2-azolyl-4,4-dimethyl-1-penten-3-ols
PH14778A (en) 4d,5d-epoxy 17b-hydroxy-4,17-dimethyl-3-oxo-androstane-2d-carbonitrile
AU3526278A (en) L-sucrose
AU3728978A (en) Sulfamoyl-aryl-ketones
CS526878A2 (en) Zpusob zpracovani pryzoveho odpadu,zejmena opotrebenych automobilovych pneumatik
AU4022878A (en) Thiopropionamides
AU4127478A (en) 6-oxygenated-3,2-dioxo-pregnane-derivatives
AU3677378A (en) N-acylmethyl-chloroacetanilides
AU3828478A (en) Benzodiazepine-diones
AU3785078A (en) Piperidino-propanols
AU3918778A (en) Beta-substituted-diketones
AU3939078A (en) 2-chlorosulfinylazetidin-4-ones
AU3774978A (en) Butyl-p-benzoylbenzoates
AU3939978A (en) 2-guanidinomethyl-indoline
AU3533578A (en) Micro-mill-mixer
AU3355078A (en) Aryl-hexafuranosides
AU4216378A (en) Antibiotic-a-40104
AU4026278A (en) Thienobenzazepines
JPS5473111A (en) Acrotine b
AU3845478A (en) Isoquinoline-diones
GB2001972B (en) Substituted 1-piperazinyl-triazolo-thieno-1,4-diazepines
GB1542605A (en) 4-tertiary-amino-2,6-diaminopyridine-1-oxides
IE45999L (en) 2-methoxybenzamides.
CS375378A1 (en) Zpusob montaze nosnych dilcu uloznych skladovych konstrukci, zejmena skladovych regalu
IE780092L (en) Phenylazacycloalkanes.

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 15